How big is the North America Sodium-Dependent Glucose Co-Transporter 2 Market?

The North America Sodium-Dependent Glucose Co-Transporter 2 Market size is expected to reach USD 7.39 billion in 2024 and grow at a CAGR of 8.67% to reach USD 10.99 billion by 2029. Read More

What is the current North America Sodium-Dependent Glucose Co-Transporter 2 Market size?

In 2024, the North America Sodium-Dependent Glucose Co-Transporter 2 Market size is expected to reach USD 7.39 billion. Read More

Who are the key players in North America Sodium-Dependent Glucose Co-Transporter 2 Market?

Janssen Pharmaceutical, Eli Lilly, AstraZeneca Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals and Astellas are the major companies operating in the North America Sodium-Dependent Glucose Co-Transporter 2 Market. Read More

What years does this North America Sodium-Dependent Glucose Co-Transporter 2 Market cover, and what was the market size in 2023?

In 2023, the North America Sodium-Dependent Glucose Co-Transporter 2 Market size was estimated at USD 6.75 billion. The report covers the North America Sodium-Dependent Glucose Co-Transporter 2 Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Sodium-Dependent Glucose Co-Transporter 2 Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America SGLT2 Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers North America SGLT2 Inhibitors Manufacturers and the Market is Segmented by Drugs (Invokana, Jardiance, and Farxiga/Forxiga) and Geography (United States, Canada, Rest of North America). The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.